Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (9) , 1420-1426
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thickerThe American Journal of Surgery, 2011
- Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus MacrometastasesJournal of Clinical Oncology, 2010
- Conditional Survival Estimates Improve Over 5 Years for Melanoma Survivors with Node-Positive DiseaseAnnals of Surgical Oncology, 2010
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?Cancer, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma PatientsAnnals of Surgical Oncology, 2009
- Regional Recurrence After Negative Sentinel Lymph Node Biopsy for MelanomaAnnals of Surgery, 2008
- Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous MelanomaJournal of Clinical Oncology, 2007
- The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanomaCancer, 2006
- Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaCancer, 2006